RFP
HRMY icon

Root Financial Partners’s Harmony Biosciences HRMY Stock Holding History

Root Financial Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$84 – 1647
2026
Q1 		$84 Hold
3
– – ﹤0.01% 3309
2025
Q4 		$112 Sell
3
-126
-98% -$4.14K ﹤0.01% 2329
2025
Q3 		$3.56K Buy
+129
New +$4.44K ﹤0.01% 1836

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Root Financial Partners's HRMY Position: Q2 2026 in Review

Root Financial Partners sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 3 shares — an estimated $84 sold.

Root Financial Partners first reported a position in HRMY in Q3 2025 and held it in 3 quarters. The position peaked at $3.56K in Q3 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Root Financial Partners reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 3 Harmony Biosciences shares in Q2 2026, an estimated $84.
  • Root Financial Partners first reported a position in Harmony Biosciences in Q3 2025 and held it in 3 quarters.
  • Root Financial Partners's Harmony Biosciences position peaked at $3.56K in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.